Federico Monaca

机构：The Christie NHS Foundation Trust

发表论文 4 篇 · 总被引 1 次 · h-index 1

代表论文

• Clinicogenomic determinants of early progression on first-line osimertinib in EGFR -mutant NSCLC. (2026 · Journal of Clinical Oncology · 被引 1)
• Post-progression treatment strategies and immunotherapy rechallenge sensitivity following chemoradiation and consolidation durvalumab in unresectable stage III NSCLC: The POST-PACIFIC study. (2026 · Journal of Clinical Oncology)
• Impact of time-of-day (ToD) of single-agent immune-checkpoint inhibitor (ICI) on survival in advanced non–small cell lung cancer (aNSCLC) with PD-L1 ≥ 50%: Analysis of the NOTCH collaborative REAL-SAIF study. (2026 · Journal of Clinical Oncology)
• Indefinite versus 2 years fixed duration of immune checkpoint inhibition in metastatic non–small cell lung cancer. (2026 · Journal of Clinical Oncology)